Epilepsy Syndromes in the First Year of Life and Usefulness of Genetic Testing for Precision Therapy
The high pace of gene discovery has resulted in thrilling advances in the field of epilepsy genetics. Clinical testing with comprehensive gene panels, exomes, or genomes are now increasingly available and have led to a significant higher diagnostic yield in early-onset epilepsies and enabled precisi...
Main Authors: | Allan Bayat, Michael Bayat, Guido Rubboli, Rikke S. Møller |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/12/7/1051 |
Similar Items
-
The Benefit of Multigene Panel Testing for the Diagnosis and Management of the Genetic Epilepsies
by: Heather Leduc-Pessah, et al.
Published: (2022-05-01) -
Genome-based therapeutics: Era of precision medicine in genetic epilepsies and epileptic encephalopathies
by: Aarthi Balaji, et al.
Published: (2023-01-01) -
Neonatal Seizures: An Overview of Genetic Causes and Treatment Options
by: Giulia Spoto, et al.
Published: (2021-09-01) -
Pediatric-Onset Epilepsy and Developmental Epileptic Encephalopathies Followed by Early-Onset Parkinsonism
by: Carlotta Spagnoli, et al.
Published: (2023-02-01) -
Benign and severe early-life seizures: a round in the first year of life
by: Piero Pavone, et al.
Published: (2018-05-01)